Czechia· CZ-0290658
JASCAYD
A nerandomilast product containing nerandomilast, registered in Czechia by Boehringer Ingelheim International GmbH, Ingelheim am Rhein. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Nerandomilast is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AA61 (nerandomilast), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Nerandomilast · ATC L04AA61
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NERANDOMILAST
- Manufacturer
- Boehringer Ingelheim International GmbH, Ingelheim am Rhein
- Country
- Czechia (CZ)
- ATC code
- L04AA61
- ATC class
- Nerandomilast
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nerandomilast in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesJASCAYDBoehringer Ingelheim Pharmaceuticals, Inc.
- FinlandJascaydBoehringer Ingelheim International GmbH
- BelgiumJascayd 18 mgBoehringer Ingelheim International
- NetherlandsJascayd 18 mg filmomhulde tablettenBoehringer Ingelheim International GmbH
- PolandJascaydBoehringer Ingelheim International GmbH
- SwedenJascayd 18 mg Filmdragerad tablettBoehringer Ingelheim International GmbH
- IrelandJascayd 18 mg film-coated tabletsBoehringer Ingelheim International GmbH
- SpainJASCAYD 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULABoehringer Ingelheim International Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jascayd
- Liechtenstein · Jascayd
- Norway · Jascayd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6513ca1a-6545-4768-86d1-536886d37e8b GET /v1/drugs/6513ca1a-6545-4768-86d1-536886d37e8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "18MG",
"pack_size": "180",
"substance": "NERANDOMILAST",
"cz_kod_sukl": "0290658",
"product_type": "CH",
"substance_codes": "3043",
"registration_state": "R",
"registration_number": "EU/1/26/2040/010"
}See everything about nerandomilast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.